Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion type Assertion NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_head.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion evidence source_evidence_literature NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion SIO_000772 21308409 NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion wasDerivedFrom befree-20150227 NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion wasGeneratedBy ECO_0000203 NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.